Boston Scientific has put its 24-acre Minnetonka, Minnesota, campus up for sale as it continues to expand in Maple Grove — another Minneapolis suburb about 10 miles to the north. The Minnesota Star Tribune first reported the news about the listing of the campus. The CBRE listing notes that Boston Scientific has had a presence […]
Boston Scientific
Upcoming DeviceTalks Minnesota is nearly sold out
Engineers, executives and entrepreneurs from across the medical device industry will gather at DeviceTalks Minnesota next Wednesday — June 11 — for a day full of discussion on the future of the industry. If you want to be part of the June 11 event, don’t wait. The event — scheduled for June 11 at the McNamara […]
Boston Scientific’s longtime DEI, HR leader exits for chief HR role at new company
Camille Chang Gilmore, Boston Scientific’s longtime global chief diversity, equity and inclusion officer and vice president of human resources, announced she is leaving the company after two decades of service. In a public statement shared on LinkedIn, Gilmore described her departure as the close of an “extraordinary” chapter and said she would be stepping into […]
Boston Scientific discontinues Acurate TAVR sales, cites regulatory burden
Boston Scientific has discontinued global sales of its Acurate neo2 and Acurate Prime transcatheter aortic valve replacement (TAVR) systems and will no longer pursue regulatory approval for the devices. The decision follows recent discussions with regulators in the U.S. and Europe, which led to heightened clinical and regulatory requirements. Boston Scientific said the additional resources […]
The biggest cardiovascular tech news out of EuroPCR 2025
This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR 2025 in Paris. The latest edition of EuroPCR delivered updates on technologies like intravascular lithotripsy (IVL), replacement heart valves, drug-eluting stents and many, many more innovative offerings. Usual suspects in the cardiovascular space like Edwards, Johnson & […]
Boston Scientific Acurate neo2 fails to meet non-inferiority in study
A recent study found the Boston Scientific Acurate neo2 heart valve failed to stack up to other commercial valves at one year. Investigators evaluated the Acurate neo2 open-cell, supra-annular, self-expanding transcatheter aortic valve replacement (TAVR) in the ACURATE-IDE randomized trial. The valve is commercially available in more than 50 countries but hasn’t been evaluated in […]
Boston Scientific has positive real-world Acurate Prime TAVI data
Boston Scientific today shared real-world clinical data backing its Acurate Prime aortic valve system. Dr. Andreas Rück, head of the transcatheter aortic valve implantation (TAVI) program at Karolinska University Hospital in Stockholm, Sweden, presented key findings from the Early ACURATE Prime Registry at EuroPCR in Paris. It marks the first large, real-world clinical data on […]
Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech
Medtronic and Boston Scientific both face patient lawsuits related to spinal cord stimulation (SCS) technologies. The Minnesota Star Tribune reported last week that, in a lawsuit filed in Minnesota, patients alleged that Medtronic circumvented necessary regulatory approvals as it continued to update its SCS systems over several decades. Similar complaints target Boston Scientific and its […]
Boston Scientific completes SoniVie acquisition
Boston Scientific announced today that it completed its previously announced acquisition of SoniVie. In March, Boston Scientific announced that it agreed to acquire the intravascular ultrasound system developer. This acquisition brings Boston Scientific into the now-competitive renal denervation (RDN) space. Recor Medical received a landmark FDA nod for its Paradise ultrasound-based RDN system in November 2023. […]
The top cardiac tech stories out of HRS 2025
The biggest names in cardiac care gathered in San Diego for the Heart Rhythm Society (HRS) 2025 Annual Meeting. Topics ranged from pulsed field ablation (PFA) to insertable cardiac monitors, with AI and other technologies also generating interest. All of the data shared at HRS 2024 demonstrated the never-ending innovation in cardiac care, while also […]
Boston Scientific has positive ICD, Watchman FLX, AI data
Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting in San Diego. Findings supported the Marlborough, Massachusetts-based company’s technologies for stroke prevention and cardiac rhythm management. Studies evaluated the company’s implantable cardioverter defibrillators (ICDs), left atrial appendage closure (LAAC) technology and AI platforms. “Data presented from […]
